Ameloblastic carcinoma ex ameloblastoma: report of a case-possible involvement of CpG island hypermethylation of the p16 gene in malignant transformation

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 103, Issue 1, 2007, Pages 72-76

  Abiko, Yoshihiro ^a   Nagayasu, Hiroki ^a   Takeshima, Maiko ^a   Yamazaki, Mami ^a   Nishimura, Michiko ^a   Kusano, Kaoru ^a   Kitajo, Hiroyuki ^a   Saitoh, Masato ^a   Kawakami, Tomofumi ^a   Chiba, Itsuo ^a   Kaku, Tohru ^a  

^a HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; DNA; DNA BINDING PROTEIN; PDRG1 PROTEIN, HUMAN;

AGED; AMELOBLASTOMA; ARTICLE; CASE REPORT; CELL TRANSFORMATION; CPG ISLAND; DNA METHYLATION; GENETICS; HUMAN; MALE; MANDIBLE TUMOR; PATHOLOGY; TUMOR SUPPRESSOR GENE;

AGED; AMELOBLASTOMA; CADHERINS; CELL TRANSFORMATION, NEOPLASTIC; CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; DNA-BINDING PROTEINS; GENES, P16; GENES, P53; HUMANS; MALE; MANDIBULAR NEOPLASMS;

EID: 33845436798     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2006.01.021     Document Type: Article

References (27)

1. In: Barnes L., Eveson J.W., Reichart P., and Sidransky D. (Eds). World Health Organization classification of tumours: pathology and genetics head and neck tumours (2005), International Agency for Research on Cancer Press, Lyon, France
2. Finlay C.A., Hinds P.W., and Levine A.J. The p53 proto-oncogene can act as a suppressor of transformation. Cell 57 (1989) 1083-1093
3. Nigro J.M., Baker S.J., Preisinger A.C., Jessup J.M., Hostetter R., Cleary K., et al. Mutations in the p53 gene occur in diverse human tumor type. Nature 342 (1989) 705-708
4. Baylin S.B., Esteller M., Rountree M.R., Bachman K.E., Schuebel K., and Herman J.G. Aberrant pattern of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet 10 (2001) 687-692
5. Toyota M., and Issa J.P. CpG island methylation phenotypes in aging and cancer. Semin Cancer Biol 9 (1999) 349-357
6. Jones P.A., and Laird P.W. Cancer epigenetics comes of age. Nat Genet 21 (1999) 163-167
7. Rocco J.W., and Sidransky D. p16 (MTS-1/CDKN2/INK4a) in cancer progression. Exp Cell Res 264 (2001) 42-55
8. Kresty L.A., Mallery S.R., Knobloch T.J., Song H., Lloyd M., Casto B.C., et al. Alteration of p16INK4a and p14ARF in patients with severe oral epithelial dysplasia. Cancer Res 62 (2001) 5295-5300
9. Viswanathan M., Tsuchida N., and Shanmugam G. Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma. Int J Cancer 105 (2003) 41-46
10. Chen Q., Lipkina G., Song Q., and Kramer R.H. Promoter methylation regulates cadherin switching in squamous cell carcinoma. Biochem Biophysi Res Commun 315 (2004) 850-856
11. Szyf M. DNA methylation and demethylation as targets for anticancer therapy. Biochemistry (Mosc) 70 (2005) 533-549
12. Elzay R.P. Primary intraosseous carcinoma of the jaws. Review and update of odontogenic carcinoma. Oral Surg Oral Med Oral Pathol 54 (1982) 299-303
13. Slootweg P.J., and Muller H. Malignant ameloblastoma or ameloblastic carcinoma. Oral Surg Oral Med Oral Pathol 57 (1984) 168-176
14. Andersen E., and Bang G. Ameloblastic carcinoma of the maxilla. a case report. J Maxillofac Surg 14 (1986) 338-340
15. Corio R.L., Goldblatt L.I., Edwards P.A., and Hartman K.S. Ameloblastic carcinoma. a clinicopathologic study and assessment of eight cases. Oral Surg Oral Med Oral Pathol 64 (1987) 570-576
16. Simko E.J., Brannon R.B., and Eibling D.E. Ameloblastic carcinoma of the mandible. Head Neck 20 (1998) 654-659
17. Avon S.L., McComb J., and Clokie C. Ameloblastic carcinoma. case report and literature review. J Can Dent Assoc 69 (2003) 573-576
18. In: Kramer I.R., Pindborg J.J., and Shear M. (Eds). WHO histological typing of odontogenic tumours (1992), Springer-Verlag, Berlin 11-27
19. Gnepp D.R., Brandwein-Gensier M.S., El-Naggar A.K., and Nagao T. Carcinoma ex pleomorphic adenoma. In: Barnes L., Eveson J.W., Reichart P., and Sidransky D. (Eds). World Health Organization classification of tumours: pathology and genetics head and neck tumours (2005), International Agency for Research on Cancer Press, Lyon, France 242-244
20. Shibata T., Nakata D., Chiba I., Yamashita T., Abiko Y., Tada M., et al. Detection of TP53 mutation in ameloblastoma by the use of a yeast functional assay. J Oral Pathol Med 31 (2002) 534-538
21. Ko L.J., and Prives C. p53: puzzle and paradigm. Genes Dev 10 (1996) 1054-1072
22. Chiba I., Muthumala M., Yamazaki Y., Uz-Zaman A., Iizuka T., Amemiya A., et al. Characteristics of mutations in the p53 gene of oral squamous cell carcinomas associated with betel quid chewing in Sri Lanka. Int J Cancer 77 (1998) 839-842
23. Kumamoto H., Izutsu T., Ohki K., Takahashi N., and Ooya K. p53 gene status and expression of p53, MDM2 and p14ARF protein in ameloblastomas. J Oral Pathol Med 33 (2004) 292-299
24. Feinberg A.P. Cancer epigenetics takes center stage. Proc Natl Acad Sci U S A 98 (2001) 392-394
25. Robertson M.D. DNA methylation, methyltransferases and cancer. Oncogene 20 (2001) 3139-3155
26. Kumamoto H., Kimi K., and Ooya K. Detection of cell cycle-related factors in ameloblastoma. J Oral Pathol Med 30 (2001) 309-315
27. Nodit L., Barnes L., Childers E., Finkelstein S., Swalsky P., and Hunt J. Allelic loss of tumor suppressor genes in ameloblastic tumors. Mod Pathol 17 (2004) 1062-1067